Inventor
DINA DINO
US38 patents
⚠️ This page may combine multiple inventors who share the name “DINA DINO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DYNAVAX TECH CORP
11 patentsUS7255868B2Aug 14, 2007
Chimeric immunomodulatory compounds and methods of using the same—I
DYNAVAX TECH CORP83 citations99
US6589940B1Jul 8, 2003
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
DYNAVAX TECH CORP325 citations99
US7250403B2Jul 31, 2007
Biodegradable immunomodulatory formulations and methods for use thereof
DYNAVAX TECH CORP71 citations97
US7183111B2Feb 27, 2007
Immunomodulatory formulations and methods for use thereof
DYNAVAX TECH CORP76 citations97
US8003115B2Aug 23, 2011
Chimeric immunomodulatory compounds and methods of using the same
DYNAVAX TECH CORP41 citations96
US8372413B2Feb 12, 2013
Immunomodulatory polynucleotides and methods of using the same
DYNAVAX TECH CORP30 citations93
US9422564B2Aug 23, 2016
Immunostimulatory sequence oligonucleotides and methods of using the same
DYNAVAX TECH CORP15 citations92
US9028845B2May 12, 2015
Chimeric immunomodulatory compounds and methods of using the same-IV
DYNAVAX TECH CORP10 citations92
US7785610B2Aug 31, 2010
Chimeric immunomodulatory compounds and methods of using the same—III
DYNAVAX TECH CORP39 citations92
US7745606B2Jun 29, 2010
Immunostimulatory sequence oligonucleotides and methods of using the same
DYNAVAX TECH CORP39 citations92
US10196643B2Feb 5, 2019
Immunostimulatory sequence oligonucleotides and methods of using the same
DYNAVAX TECH CORP8 citations84
NOVARTIS VACCINES & DIAGNOSTIC
9 patentsUS7285271B1Oct 23, 2007
Antigenic composition comprising an HIV gag or env polypeptide
NOVARTIS VACCINES & DIAGNOSTIC10 citations84
US7273695B1Sep 25, 2007
HIV immunoassays using synthetic envelope polypeptides
NOVARTIS VACCINES & DIAGNOSTIC10 citations84
US7393949B1Jul 1, 2008
Human immunodeficiency virus (HIV) nucleotide sequences
NOVARTIS VACCINES & DIAGNOSTIC10 citations81
US7442525B1Oct 28, 2008
Method for expressing HIV polypeptides
NOVARTIS VACCINES & DIAGNOSTIC3 citations63
US7408053B1Aug 5, 2008
Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby
NOVARTIS VACCINES & DIAGNOSTIC1 citations63
US7205101B1Apr 17, 2007
Human immunodeficiency virus (HIV) nucleotide sequences, recombinant polypeptides, and applications thereof
NOVARTIS VACCINES & DIAGNOSTIC2 citations63
USRE41158EMar 2, 2010
Human immunodeficiency virus (HIV) nucleotide sequences
NOVARTIS VACCINES & DIAGNOSTIC1 citations60
US7425428B1Sep 16, 2008
Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby
NOVARTIS VACCINES & DIAGNOSTIC1 citations60
US7527925B1May 5, 2009
Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct
NOVARTIS VACCINES & DIAGNOSTIC0 citations49
CHIRON CORP
8 patentsUS5156949AOct 20, 1992
Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
CHIRON CORP112 citations97
US5688688ANov 18, 1997
Vector for expression of a polypeptide in a mammalian cell
CHIRON CORP54 citations94
US6531276B1Mar 11, 2003
Methods for detecting human immunodeficiency virus nucleic acid
CHIRON CORP28 citations92
US6458527B1Oct 1, 2002
HIV immunoassays using gag polypeptides
CHIRON CORP27 citations92
US6096505AAug 1, 2000
Noncloning technique for expressing a gene of interest
CHIRON CORP47 citations92
US6013432AJan 11, 2000
Immunoassay of HIV antibodies using recombinant or synthetic selected pol sequence
CHIRON CORP17 citations92
US5206163AApr 27, 1993
DNA encoding bovine diarrhea virus protein
CHIRON CORP59 citations92
US5152982AOct 6, 1992
Compositions and methods for FeLV vaccination
CHIRON CORP3 citations61
FEARON KAREN L
4 patentsUS8114418B2Feb 14, 2012
Chimeric immunomodulatory compounds and methods of using the same—IV
FEARON KAREN L32 citations95
US8597665B2Dec 3, 2013
Chimeric immunomodulatory compounds and methods of using the same-IV
FEARON KAREN L16 citations92
US8222398B2Jul 17, 2012
Chimeric immunomodulatory compounds and methods of using the same-II
FEARON KAREN L16 citations92
US8586555B2Nov 19, 2013
Immunomodulatory compositions, formulations, and methods for use thereof
FEARON KAREN L12 citations84